SCHEMBL7899238

SCHEMBL7899238

C=C1C=C(C(=O)N(C(=N)N)N2CCNCC2)C=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7897637 0.82 HTR2A (0.30)
SCHEMBL7900624 0.72 SIGMAR1 (0.42)
SCHEMBL7898795 0.71
SCHEMBL7897661 0.62 SLC6A4 (0.42)
SCHEMBL10956840 0.62
SCHEMBL8347053 0.61 SIGMAR1 (0.32)
SCHEMBL28770204 0.58 SIGMAR1 (0.50)
SCHEMBL3921615 0.58 NOS2 (0.34)
SCHEMBL9391092 0.56 CA2 (0.39)
SCHEMBL3916305 0.55 NOS2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6191273-B1 3,6,10,14-SUBSTITUTED-3,6,10,16-TETRAAZABICYCLO(10.3.1)-HEXADE CA-1(16),12,14-TRIENE COMPOUNDS OF GIVEN FORMULA; ANTIBACTERIAL AND OTHER UTILITIES, SUCH AS TO SCREEN FOR PESTICIDES OR DRUGS ISIS PHARMACEUTICALS, INC. 2001-02-20 US disclosed
WO-1999011612-A2 SUBSTITUTED CYCLIC COMPOUNDS AND MIXTURES COMPRISING SAME ISIS PHARMACEUTICALS, INC. (US) 1999-03-11 WO disclosed